logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Herman F Staats

This inventor holds 8 USPTO granted patents. Top assignees: Duke University, Other. Active years: 2001-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Herman F Staats. Retrieved from https://idiyas.com/inventor/herman-f-staats

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 75.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Durham, NC (US) (2001 - 2006)
  • Hillsborough, NC (US) (2011)
  • Cedar Grove, NC (US) (2014 - 2019)

Company Filing History:

goldMedal7 out of 2,084 
 
Duke University
 patents
silverMedal1 out of 834,513 
Other
 patents

Years Active: 2001-2019

Loading Chart...
8 patents (USPTO):Explore Patents
1. 10245319 - Lymph node-targeting nanoparticles (2019-04-02),
2. 9782475 - Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12 (2017-10-10),
3. 9301999 - Peptide, adjuvants, vaccines, and methods of use (2016-04-05),
4. 8802076 - Compositions and methods for modulating an immune response (2014-08-12),
5. 8076059 - Adjuvant capable of specifically activating the adaptive immune response (2011-12-13),
6. 7041294 - Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects (2006-05-09),
7. 6656462 - Interleukin-1 muteins useful as vaccine adjuvants (2003-12-02),
8. 6270758 - Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects (2001-08-07),

Title: The Innovative Mind of Herman F Staats

Introduction

Herman F Staats is a prominent inventor based in Durham, NC, known for his significant contributions to the field of biomedical innovations. With a portfolio of 8 patents, he has made substantial advancements in the development of nanoparticles for medical applications, particularly in targeting lymph nodes and treating food allergies.

Latest Patents

Staats’s latest patents focus on lymph node-targeting nanoparticles, which comprise heparin, chitosan, and at least one immunomodulatory agent, such as a cytokine. This innovative approach offers methods for creating nanoparticles by mixing heparin and chitosan in the presence of cytokines. Additionally, his work includes methods for modulating immune responses through the co-administration of these nanoparticles with antigens or vaccines. Another crucial patent involves a method for treating food allergies by administering nanoparticles encapsulating IL-12, reinforcing Staats's focus on improving health outcomes through advanced biotechnological solutions.

Career Highlights

Throughout his career, Staats has been associated with notable institutions, particularly Duke University, where he has contributed to pioneering research initiatives. His expertise in nanoparticle technology has placed him at the forefront of inventions aimed at revolutionizing medical treatments and improving patient care.

Collaborations

Staats has collaborated with esteemed colleagues such as Soman N Abraham and Kam W Leong. These partnerships have further enriched his research, bringing together diverse expertise in the fields of immunology and nanotechnology to enhance the effectiveness of his inventions.

Conclusion

Herman F Staats continues to be a source of inspiration and innovation, pushing the boundaries of science through his patented inventions. His dedication to advancing medical technology through nanoparticles holds promise for future breakthroughs in treating various health conditions, making him a significant figure in the realm of biomedical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…